Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

574 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Colon cancer transcriptome.
Mokhtari K, Peymani M, Rashidi M, Hushmandi K, Ghaedi K, Taheriazam A, Hashemi M. Mokhtari K, et al. Among authors: rashidi m. Prog Biophys Mol Biol. 2023 Jul-Aug;180-181:49-82. doi: 10.1016/j.pbiomolbio.2023.04.002. Epub 2023 Apr 13. Prog Biophys Mol Biol. 2023. PMID: 37059270 Review.
Non-coding RNAs and macrophage interaction in tumor progression.
Entezari M, Sadrkhanloo M, Rashidi M, Asnaf SE, Taheriazam A, Hashemi M, Ashrafizadeh M, Zarrabi A, Rabiee N, Hushmandi K, Mirzaei S, Sethi G. Entezari M, et al. Among authors: rashidi m. Crit Rev Oncol Hematol. 2022 May;173:103680. doi: 10.1016/j.critrevonc.2022.103680. Epub 2022 Apr 9. Crit Rev Oncol Hematol. 2022. PMID: 35405273 Review.
STAT3-EMT axis in tumors: Modulation of cancer metastasis, stemness and therapy response.
Sadrkhanloo M, Entezari M, Orouei S, Ghollasi M, Fathi N, Rezaei S, Hejazi ES, Kakavand A, Saebfar H, Hashemi M, Goharrizi MASB, Salimimoghadam S, Rashidi M, Taheriazam A, Samarghandian S. Sadrkhanloo M, et al. Among authors: rashidi m. Pharmacol Res. 2022 Aug;182:106311. doi: 10.1016/j.phrs.2022.106311. Epub 2022 Jun 15. Pharmacol Res. 2022. PMID: 35716914 Review.
Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges.
Paskeh MDA, Ghadyani F, Hashemi M, Abbaspour A, Zabolian A, Javanshir S, Razzazan M, Mirzaei S, Entezari M, Goharrizi MASB, Salimimoghadam S, Aref AR, Kalbasi A, Rajabi R, Rashidi M, Taheriazam A, Sethi G. Paskeh MDA, et al. Among authors: rashidi m. Pharmacol Res. 2023 Jan;187:106553. doi: 10.1016/j.phrs.2022.106553. Epub 2022 Nov 15. Pharmacol Res. 2023. PMID: 36400343 Free article. Review.
Pre-clinical and clinical importance of miR-21 in human cancers: Tumorigenesis, therapy response, delivery approaches and targeting agents.
Hashemi M, Mirdamadi MSA, Talebi Y, Khaniabad N, Banaei G, Daneii P, Gholami S, Ghorbani A, Tavakolpournegari A, Farsani ZM, Zarrabi A, Nabavi N, Zandieh MA, Rashidi M, Taheriazam A, Entezari M, Khan H. Hashemi M, et al. Among authors: rashidi m. Pharmacol Res. 2023 Jan;187:106568. doi: 10.1016/j.phrs.2022.106568. Epub 2022 Nov 21. Pharmacol Res. 2023. PMID: 36423787 Free article. Review.
Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategies.
Hashemi M, Zandieh MA, Talebi Y, Rahmanian P, Shafiee SS, Nejad MM, Babaei R, Sadi FH, Rajabi R, Abkenar ZO, Rezaei S, Ren J, Nabavi N, Khorrami R, Rashidi M, Hushmandi K, Entezari M, Taheriazam A. Hashemi M, et al. Among authors: rashidi m. Biomed Pharmacother. 2023 Apr;160:114392. doi: 10.1016/j.biopha.2023.114392. Epub 2023 Feb 15. Biomed Pharmacother. 2023. PMID: 36804123 Free article. Review.
574 results